Publication | Closed Access

High Variation of Intravitreal Injection Rates and Medicare Anti–Vascular Endothelial Growth Factor Payments per Injection in the United States

Cardiovascular DiseaseHealth PolicyHealth EconomicsIntravitreal Injection RatesHealth InsuranceVascular SurgeryVascular AccessNeovascularizationPublic HealthMedicineUnited StatesHigh Variation